References

Atsma F, Bartelink MLEL, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause.. 2006; 13:(2)265-279 https://doi.org/10.1097/01.gme.0000218683.97338.ea

British Heart Foundation. National Audit of Cardiac Rehabilitation (NACR) Quality and Outcomes Report 2019. 2019b. https://www.bhf.org.uk/informationsupport/publications/statistics/national-audit-of-cardiac-rehabilitation-quality-and-outcomes-report-2019 (accessed 4 February 2021)

British Heart Foundation. Heart statistics: BHF statistics fact sheet. 2021. https://www.bhf.org.uk/what-we-do/our-research/heart-statistics (accessed 4 February 2021)

Bucciarelli V, Caterino AL, Bianco F, Caputi CG, Salerni S, Sciomer S, Maffei S, Gallina S. Depression and cardiovascular disease: the deep blue sea of women's heart. Trends Cardiovasc Med.. 2020; 30:(3)170-176 https://doi.org/10.1016/j.tcm.2019.05.001

Bugiardini R, Ricci B, Cenko E Delayed Care and Mortality Among Women and Men With Myocardial Infarction. J Am Heart Assoc.. 2017; 6:(8) https://doi.org/10.1161/JAHA.117.005968

Chester RC, Kling JM, Manson JE. What the Women's Health Initiative has taught us about menopausal hormone therapy. Clin Cardiol.. 2018; 41:(2)247-252 https://doi.org/10.1002/clc.22891

Dulicek P, Ivanova E, Kostal M Analysis of Risk Factors of Stroke and Venous Thromboembolism in Females With Oral Contraceptives Use. Clin Appl Thromb Hemost.. 2018; 24:(5)797-802 https://doi.org/10.1177/1076029617727857

European Society of Cardiology. The collateral damage of COVID-19: cardiovascular disease, the next pandemic wave. 2020. https://www.escardio.org/The-ESC/Advocacy/Shaping-policy-and-regulation/ESC-positions/the-collateral-damage-of-covid-19-cardiovascular-disease-the-next-pandemic-wav (accessed 4 February 2021)

Ferry AV, Anand A, Strachan FE Presenting Symptoms in Men and Women Diagnosed With Myocardial Infarction Using Sex-Specific Criteria. J Am Heart Assoc.. 2019; 8:(17) https://doi.org/10.1161/JAHA.119.012307

Gordon JL, Rubinow DR, Watkins L, Hinderliter AL, Caughey MC, Girdler SS. The Effect of perimenopausal transdermal estradiol and micronized progesterone on markers of risk for arterial disease. J Clin Endocrinol Metab.. 2020; 105:(5)e2050-e2060 https://doi.org/10.1210/clinem/dgz262

Grandi SM, Filion KB, Yoon S Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications. Circulation.. 2019; 139:(8)1069-1079 https://doi.org/10.1161/CIRCULATIONAHA.118.036748

Gunning MN, Meun C, van Rijn BB The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: A case-control study. PLoS One.. 2020; 15:(3) https://doi.org/10.1371/journal.pone.0229576

Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA.. 1979; 241:(19)2035-2038 https://doi.org/10.1001/jama.1979.03290450033020

Mattina GF, Van Lieshout RJ, Steiner M. Inflammation, depression and cardiovascular disease in women: the role of the immune system across critical reproductive events. Ther Adv Cardiovasc Dis.. 2019; 13 https://doi.org/10.1177/1753944719851950

Mentzer G, Hsich EM. Heart Failure with Reduced Ejection Fraction in Women. Heart Fail Clin.. 2019; 15:(1)19-27 https://doi.org/10.1016/j.hfc.2018.08.003

Newson L. Menopause and cardiovascular disease. Post Reprod Health.. 2018; 24:(1)44-49 https://doi.org/10.1177/2053369117749675

Nguyen HL, Saczynski JS, Gore JM, Goldberg RJ. Age and sex differences in duration of prehospital delay in patients with acute myocardial infarction: a systematic review. Circ Cardiovasc Qual Outcomes.. 2010; 3:(1)82-92 https://doi.org/10.1161/CIRCOUTCOMES.109.884361

Peters SAE, Colantonio LD, Zhao H Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States. J Am Coll Cardiol.. 2018; 71:(16)1729-1737 https://doi.org/10.1016/j.jacc.2018.02.032

Roth J, Deck G. Neurovascular disorders in pregnancy: A review. Obstet Med.. 2019; 12:(4)164-167 https://doi.org/10.1177/1753495X19825699

Saeed A, Kampangkaew J, Nambi V. Prevention of Cardiovascular Disease in Women. Methodist Debakey Cardiovasc J.. 2017; 13:(4)185-192 https://doi.org/10.14797/mdcj-13-4-185

Saw J, Mancini GBJ, Humphries KH. Contemporary review on spontaneous coronary artery dissection. J Am Coll Cardiol.. 2016; 68:(3)297-312 https://doi.org/10.1016/j.jacc.2016.05.034

Shah AS, Griffiths M, Lee KK High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ.. 2015; 350 https://doi.org/10.1136/bmj.g7873

Wilkinson C, Bebb O, Dondo TB Sex differences in quality indicator attainment for myocardial infarction: a nationwide cohort study. Heart.. 2019; 105:(7)516-523 https://doi.org/10.1136/heartjnl-2018-313959

Woodward M. Cardiovascular Disease and the Female Disadvantage. Int J Environ Res Public Health.. 2019; 16:(7) https://doi.org/10.3390/ijerph16071165

Wu J, Gale CP, Hall M Editor's Choice - Impact of initial hospital diagnosis on mortality for acute myocardial infarction: A national cohort study. Eur Heart J Acute Cardiovasc Care.. 2018; 7:(2)139-148 https://doi.org/10.1177/2048872616661693

Zhao M, Vaartjes I, Graham I Sex differences in risk factor management of coronary heart disease across three regions. Heart.. 2017; 103:(20)1587-1594 https://doi.org/10.1136/heartjnl-2017-311429

Zhu D, Chung HF, Dobson AJ Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health.. 2019; 4:(11) https://doi.org/10.1016/S2468-2667(19)30155-0

Cardiovascular disease: the gender divide

02 May 2021
8 min read
Volume 32 · Issue 5

Abstract

Cardiovascular disease is often thought of as a condition that mainly affects men. Beverley Bostock analyses the role practice nurses can play in recognising and managing cardiovascular disease in women

Although cardiovascular disease (CVD) is recognised to be a condition that affects men more than women overall, this risks underplaying the significant challenges relating to the diagnosis and management of CVD in women. Women are adversely affected compared to men in terms of diagnosis, acute management and implementation of secondary prevention, and the evidence base for treating women is lacking, due to the low numbers of women included in trials. Hormonal fluctuations throughout a woman's lifetime can also affect CVD risk. GPNs are ideally placed to consider the challenges of recognising and addressing CVD risk in women and to support them with engaging in reducing their lifetime risk.

Cardiovascular disease (CVD) is an umbrella term relating to a spectrum of conditions which affect the heart and blood vessels of the body. These vessels include the large vessels supplying the brain, heart and limbs, and the smaller vessels supplying the eyes, kidneys and nerves. Although CVD is recognised to be a condition that affects men more than women overall, this risks underplaying the significant challenges relating to the diagnosis and management of CVD in women.

In this article, we consider the incidence and prevalence of heart disease in women and analyse the role of the general practice nurse (GPN) in recognising and managing cardiovascular conditions in women. By the end of this article readers will be able to:

According to statistics from the British Heart Foundation (BHF) there are 830 000 women in the UK living with coronary heart disease (CHD), and around 380 000 women in the UK have survived a heart attack (BHF, 2021). Coronary heart disease is the single biggest killer of women in the UK and kills more than twice as many women as breast cancer (BHF, 2019a).

Register now to continue reading

Thank you for visiting Practice Nursing and reading some of our peer-reviewed resources for general practice nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month